Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Gordon

Showing results (161-170 of 388) with videos related to

Pageof 39
Sort By:
Open Forum Infectious Diseases|February 21, 2024
Impact of Potential Case Misclassification by Administrative Diagnostic Codes on Outcome Assessment of Observational Study for People Who Inject DrugsDavid Goodman-Meza, Michihiko Goto, Anabel Salimian, et al.
Substance Use & Addiction Journal|March 1, 2025
Insights Into Recovery: A Qualitative Analysis of Primary Care Provider Perspectives on Treating Veterans With Opioid Use Disorder in the VA Primary Care SettingKrista L Scorsone, Mary Ava Nunnery, Spencer Calder, et al.
Substance Use & Addiction Journal|May 20, 2024
"They Ask Questions, But They Don't Want the Answers"-Perceptions of Clinical Communication Among Veterans Discontinuing Buprenorphine for the Treatment of Opioid Use DisorderAlison Eckhardt, Dylan E Waller, Sarah Shull, et al.
Health Affairs (Project Hope)|June 10, 2015
Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11Andrew W Dick, Rosalie L Pacula, Adam J Gordon, et al.
Substance Abuse|November 15, 2015
Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013Rachel M Burns, Rosalie L Pacula, Sebastian Bauhoff, et al.
Journal of Addiction Medicine|October 31, 2015
Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid ProgramAdam J Gordon, Wei-Hsuan Lo-Ciganic, Gerald Cochran, et al.
Substance Abuse|September 16, 2020
Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorderAllison M Gustavson, Adam J Gordon, Marie E Kenny, et al.
Diabetes Care|June 1, 2014
Glucose control and medication adherence among veterans with diabetes and serious mental illness: does collocation of primary care and mental health care matter?Judith A Long, Andrew Wang, Elina L Medvedeva, et al.
Journal of Addiction Medicine|December 16, 2020
Low Uptake of Secure Messaging Among Veterans With Experiences of Homelessness and Substance Use DisordersAudrey L Jones, Lillian Gelberg, Aerin J deRussy, et al.
Substance Abuse|June 23, 2018
A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrolleesBradley D Stein, Andrew W Dick, Mark Sorbero, et al.
Pageof 39

Showing results (161-170 of 388) with videos related to

Sort By:
Pageof 39
Open Forum Infectious Diseases|February 21, 2024
Impact of Potential Case Misclassification by Administrative Diagnostic Codes on Outcome Assessment of Observational Study for People Who Inject DrugsDavid Goodman-Meza, Michihiko Goto, Anabel Salimian, et al.
Substance Use & Addiction Journal|March 1, 2025
Insights Into Recovery: A Qualitative Analysis of Primary Care Provider Perspectives on Treating Veterans With Opioid Use Disorder in the VA Primary Care SettingKrista L Scorsone, Mary Ava Nunnery, Spencer Calder, et al.
Substance Use & Addiction Journal|May 20, 2024
"They Ask Questions, But They Don't Want the Answers"-Perceptions of Clinical Communication Among Veterans Discontinuing Buprenorphine for the Treatment of Opioid Use DisorderAlison Eckhardt, Dylan E Waller, Sarah Shull, et al.
Health Affairs (Project Hope)|June 10, 2015
Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11Andrew W Dick, Rosalie L Pacula, Adam J Gordon, et al.
Substance Abuse|November 15, 2015
Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013Rachel M Burns, Rosalie L Pacula, Sebastian Bauhoff, et al.
Journal of Addiction Medicine|October 31, 2015
Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid ProgramAdam J Gordon, Wei-Hsuan Lo-Ciganic, Gerald Cochran, et al.
Substance Abuse|September 16, 2020
Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorderAllison M Gustavson, Adam J Gordon, Marie E Kenny, et al.
Diabetes Care|June 1, 2014
Glucose control and medication adherence among veterans with diabetes and serious mental illness: does collocation of primary care and mental health care matter?Judith A Long, Andrew Wang, Elina L Medvedeva, et al.
Journal of Addiction Medicine|December 16, 2020
Low Uptake of Secure Messaging Among Veterans With Experiences of Homelessness and Substance Use DisordersAudrey L Jones, Lillian Gelberg, Aerin J deRussy, et al.
Substance Abuse|June 23, 2018
A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrolleesBradley D Stein, Andrew W Dick, Mark Sorbero, et al.
Pageof 39